JPRN-UMIN000022891已完成未知
A Comparative Study of Potassium-Competitive Acid Blocker (Vonoprazan) and Proton Pomp Inhibitors in Helicobacter Pylori Eradication Therapy. - H. pylori eradication therapy
Hattori Clinic0 个研究点目标入组 1,353 人开始时间: 2016年7月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 1,353
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Others,meta-analysis etc
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Exclusion criteria were as follows: age less than 20 years, past history of total gastrectomy, history of drug allergy to PPIs, AMPC, CAM or MNZ, clinically significant disease (hepatic, renal or cardiac disease) and pregnancy.
研究者
相似试验
招募中
不适用
Comparative study of Potassium Competitive acid blocker (P-CAB) and Classic proton pomp inhibitor in clinical effectiveness for gastro-esophageal reflux symptoms :Randomized Comparative study of venoprazan and esomeprazolePatients of gastro-esophageal reflux symptomsJPRN-UMIN000021753Hattori clinic60
进行中（未招募）
不适用
Impact assessment of potassium competitive acid blocker on the gut microbiota of Anginal patientsKCT0008181Kangwon National University Hospital40
尚未招募
2 期
Efficacy of Vonoprazan in Management of Post Endoscopic Variceal Ligation UlcerDigestive SystemPACTR202207793488326General Organization for Teaching Hospitals and Institutes300
尚未招募
Unknown
Efficacy of prophylactic potassium-competitive acid blockers after catheter ablation for atrial fibrillatioKCT0009272The Catholic University of Korea, Seoul St. Mary's Hospital60
招募中
3 期
Comparison of the consequences of potassium administration with lower amounts than the estimated amount in hospitalized childreInvestigating the outcome of serum with lower amounts of potassium in children.IRCT20240513061780N1Ghoum University of Medical Sciences114